nodes	percent_of_prediction	percent_of_DWPC	metapath
Lovastatin—HDAC2—chronic obstructive pulmonary disease	0.451	1	CbGaD
Lovastatin—HDAC2—Aminophylline—chronic obstructive pulmonary disease	0.21	0.52	CbGbCtD
Lovastatin—SLCO1A2—Prednisolone—chronic obstructive pulmonary disease	0.0193	0.0476	CbGbCtD
Lovastatin—SLCO1A2—Prednisone—chronic obstructive pulmonary disease	0.0182	0.045	CbGbCtD
Lovastatin—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.0145	0.0359	CbGbCtD
Lovastatin—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.0145	0.0359	CbGbCtD
Lovastatin—CYP2C8—Montelukast—chronic obstructive pulmonary disease	0.0131	0.0324	CbGbCtD
Lovastatin—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.0121	0.0298	CbGbCtD
Lovastatin—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.0121	0.0298	CbGbCtD
Lovastatin—CYP2D6—Formoterol—chronic obstructive pulmonary disease	0.011	0.0273	CbGbCtD
Lovastatin—CYP2D6—Arformoterol—chronic obstructive pulmonary disease	0.011	0.0273	CbGbCtD
Lovastatin—CYP2D6—Tiotropium—chronic obstructive pulmonary disease	0.00983	0.0243	CbGbCtD
Lovastatin—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.00926	0.0229	CbGbCtD
Lovastatin—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.00914	0.0226	CbGbCtD
Lovastatin—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.00625	0.0155	CbGbCtD
Lovastatin—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.00609	0.0151	CbGbCtD
Lovastatin—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.00597	0.0148	CbGbCtD
Lovastatin—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.00532	0.0131	CbGbCtD
Lovastatin—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.00521	0.0129	CbGbCtD
Lovastatin—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.00492	0.0122	CbGbCtD
Lovastatin—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00312	0.00771	CbGbCtD
Lovastatin—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00295	0.00729	CbGbCtD
Lovastatin—ITGAL—respiratory system—chronic obstructive pulmonary disease	0.00196	0.118	CbGeAlD
Lovastatin—ITGAL—connective tissue—chronic obstructive pulmonary disease	0.00173	0.104	CbGeAlD
Lovastatin—ITGAL—bronchus—chronic obstructive pulmonary disease	0.00161	0.0972	CbGeAlD
Lovastatin—ITGAL—trachea—chronic obstructive pulmonary disease	0.00145	0.0873	CbGeAlD
Lovastatin—ITGAL—lung—chronic obstructive pulmonary disease	0.00104	0.0627	CbGeAlD
Lovastatin—PON3—lung—chronic obstructive pulmonary disease	0.00102	0.0615	CbGeAlD
Lovastatin—HDAC2—respiratory system—chronic obstructive pulmonary disease	0.000784	0.0472	CbGeAlD
Lovastatin—HMGCR—respiratory system—chronic obstructive pulmonary disease	0.000707	0.0426	CbGeAlD
Lovastatin—HDAC2—connective tissue—chronic obstructive pulmonary disease	0.00069	0.0416	CbGeAlD
Lovastatin—HDAC2—bronchus—chronic obstructive pulmonary disease	0.000645	0.0389	CbGeAlD
Lovastatin—HDAC2—smooth muscle tissue—chronic obstructive pulmonary disease	0.000631	0.038	CbGeAlD
Lovastatin—HMGCR—connective tissue—chronic obstructive pulmonary disease	0.000623	0.0375	CbGeAlD
Lovastatin—HMGCR—bronchus—chronic obstructive pulmonary disease	0.000582	0.0351	CbGeAlD
Lovastatin—HMGCR—smooth muscle tissue—chronic obstructive pulmonary disease	0.00057	0.0343	CbGeAlD
Lovastatin—HMGCR—trachea—chronic obstructive pulmonary disease	0.000523	0.0315	CbGeAlD
Lovastatin—HDAC2—lung—chronic obstructive pulmonary disease	0.000416	0.0251	CbGeAlD
Lovastatin—HMGCR—lung—chronic obstructive pulmonary disease	0.000376	0.0226	CbGeAlD
Lovastatin—CYP3A5—respiratory system—chronic obstructive pulmonary disease	0.000348	0.0209	CbGeAlD
Lovastatin—SLCO1A2—lung—chronic obstructive pulmonary disease	0.000293	0.0176	CbGeAlD
Lovastatin—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000239	0.00322	CcSEcCtD
Lovastatin—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000238	0.00322	CcSEcCtD
Lovastatin—Headache—Roflumilast—chronic obstructive pulmonary disease	0.000237	0.0032	CcSEcCtD
Lovastatin—Flushing—Salbutamol—chronic obstructive pulmonary disease	0.000237	0.0032	CcSEcCtD
Lovastatin—Infection—Tiotropium—chronic obstructive pulmonary disease	0.000236	0.00319	CcSEcCtD
Lovastatin—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.000231	0.00311	CcSEcCtD
Lovastatin—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.000231	0.00311	CcSEcCtD
Lovastatin—Injury—Prednisolone—chronic obstructive pulmonary disease	0.00023	0.00311	CcSEcCtD
Lovastatin—Chills—Salbutamol—chronic obstructive pulmonary disease	0.000229	0.00309	CcSEcCtD
Lovastatin—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.000228	0.00308	CcSEcCtD
Lovastatin—Back pain—Formoterol—chronic obstructive pulmonary disease	0.000228	0.00308	CcSEcCtD
Lovastatin—Back pain—Arformoterol—chronic obstructive pulmonary disease	0.000228	0.00308	CcSEcCtD
Lovastatin—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.000226	0.00306	CcSEcCtD
Lovastatin—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.000226	0.00306	CcSEcCtD
Lovastatin—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000225	0.00304	CcSEcCtD
Lovastatin—Cataract—Prednisone—chronic obstructive pulmonary disease	0.000223	0.00301	CcSEcCtD
Lovastatin—Dyspepsia—Aminophylline—chronic obstructive pulmonary disease	0.000222	0.003	CcSEcCtD
Lovastatin—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000222	0.00299	CcSEcCtD
Lovastatin—Tremor—Arformoterol—chronic obstructive pulmonary disease	0.000221	0.00298	CcSEcCtD
Lovastatin—Tremor—Formoterol—chronic obstructive pulmonary disease	0.000221	0.00298	CcSEcCtD
Lovastatin—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000219	0.00296	CcSEcCtD
Lovastatin—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.000219	0.00296	CcSEcCtD
Lovastatin—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.000218	0.00295	CcSEcCtD
Lovastatin—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.000218	0.00295	CcSEcCtD
Lovastatin—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000218	0.00294	CcSEcCtD
Lovastatin—Vasculitis—Prednisone—chronic obstructive pulmonary disease	0.000217	0.00293	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.000217	0.00293	CcSEcCtD
Lovastatin—Tremor—Montelukast—chronic obstructive pulmonary disease	0.000216	0.00292	CcSEcCtD
Lovastatin—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.000215	0.00291	CcSEcCtD
Lovastatin—Angioedema—Formoterol—chronic obstructive pulmonary disease	0.000215	0.0029	CcSEcCtD
Lovastatin—Angioedema—Arformoterol—chronic obstructive pulmonary disease	0.000215	0.0029	CcSEcCtD
Lovastatin—Back pain—Salbutamol—chronic obstructive pulmonary disease	0.000215	0.0029	CcSEcCtD
Lovastatin—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000214	0.00289	CcSEcCtD
Lovastatin—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000214	0.00289	CcSEcCtD
Lovastatin—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.000212	0.00287	CcSEcCtD
Lovastatin—Malaise—Formoterol—chronic obstructive pulmonary disease	0.000212	0.00287	CcSEcCtD
Lovastatin—Angioedema—Montelukast—chronic obstructive pulmonary disease	0.000211	0.00285	CcSEcCtD
Lovastatin—Dyspepsia—Tiotropium—chronic obstructive pulmonary disease	0.00021	0.00283	CcSEcCtD
Lovastatin—Tremor—Salbutamol—chronic obstructive pulmonary disease	0.000208	0.00281	CcSEcCtD
Lovastatin—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000206	0.00279	CcSEcCtD
Lovastatin—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.000206	0.00279	CcSEcCtD
Lovastatin—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000204	0.00275	CcSEcCtD
Lovastatin—Angioedema—Salbutamol—chronic obstructive pulmonary disease	0.000203	0.00274	CcSEcCtD
Lovastatin—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000201	0.00271	CcSEcCtD
Lovastatin—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.0002	0.00271	CcSEcCtD
Lovastatin—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.0002	0.00271	CcSEcCtD
Lovastatin—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.0002	0.00271	CcSEcCtD
Lovastatin—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.0002	0.00271	CcSEcCtD
Lovastatin—Chest pain—Formoterol—chronic obstructive pulmonary disease	0.0002	0.00271	CcSEcCtD
Lovastatin—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.0002	0.00271	CcSEcCtD
Lovastatin—Chest pain—Arformoterol—chronic obstructive pulmonary disease	0.0002	0.00271	CcSEcCtD
Lovastatin—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.0002	0.0027	CcSEcCtD
Lovastatin—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.0002	0.0027	CcSEcCtD
Lovastatin—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.0002	0.0027	CcSEcCtD
Lovastatin—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.0002	0.0027	CcSEcCtD
Lovastatin—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.0002	0.0027	CcSEcCtD
Lovastatin—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000198	0.00267	CcSEcCtD
Lovastatin—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.000198	0.00267	CcSEcCtD
Lovastatin—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.000196	0.00265	CcSEcCtD
Lovastatin—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.000196	0.00265	CcSEcCtD
Lovastatin—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000196	0.00265	CcSEcCtD
Lovastatin—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000196	0.00265	CcSEcCtD
Lovastatin—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.000196	0.00264	CcSEcCtD
Lovastatin—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000195	0.00263	CcSEcCtD
Lovastatin—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000192	0.00259	CcSEcCtD
Lovastatin—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000192	0.00259	CcSEcCtD
Lovastatin—Infection—Arformoterol—chronic obstructive pulmonary disease	0.000191	0.00258	CcSEcCtD
Lovastatin—Infection—Formoterol—chronic obstructive pulmonary disease	0.000191	0.00258	CcSEcCtD
Lovastatin—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000189	0.00256	CcSEcCtD
Lovastatin—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.000189	0.00256	CcSEcCtD
Lovastatin—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.000189	0.00256	CcSEcCtD
Lovastatin—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000189	0.00255	CcSEcCtD
Lovastatin—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000189	0.00255	CcSEcCtD
Lovastatin—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000188	0.00254	CcSEcCtD
Lovastatin—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000188	0.00254	CcSEcCtD
Lovastatin—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000187	0.00253	CcSEcCtD
Lovastatin—Infection—Montelukast—chronic obstructive pulmonary disease	0.000187	0.00252	CcSEcCtD
Lovastatin—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000186	0.00251	CcSEcCtD
Lovastatin—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000185	0.0025	CcSEcCtD
Lovastatin—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.000185	0.0111	CbGeAlD
Lovastatin—CYP3A5—lung—chronic obstructive pulmonary disease	0.000185	0.0111	CbGeAlD
Lovastatin—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000184	0.00249	CcSEcCtD
Lovastatin—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000181	0.00245	CcSEcCtD
Lovastatin—Infection—Salbutamol—chronic obstructive pulmonary disease	0.00018	0.00243	CcSEcCtD
Lovastatin—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000179	0.00242	CcSEcCtD
Lovastatin—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000179	0.00241	CcSEcCtD
Lovastatin—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000175	0.00237	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000175	0.00236	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000175	0.00236	CcSEcCtD
Lovastatin—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000174	0.00235	CcSEcCtD
Lovastatin—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000174	0.00235	CcSEcCtD
Lovastatin—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000173	0.00234	CcSEcCtD
Lovastatin—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000173	0.00233	CcSEcCtD
Lovastatin—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000172	0.00232	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000171	0.00232	CcSEcCtD
Lovastatin—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000171	0.00231	CcSEcCtD
Lovastatin—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000171	0.00231	CcSEcCtD
Lovastatin—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00017	0.0023	CcSEcCtD
Lovastatin—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000169	0.00228	CcSEcCtD
Lovastatin—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000169	0.00228	CcSEcCtD
Lovastatin—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000169	0.00228	CcSEcCtD
Lovastatin—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000168	0.00227	CcSEcCtD
Lovastatin—Injury—Prednisone—chronic obstructive pulmonary disease	0.000167	0.00226	CcSEcCtD
Lovastatin—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000167	0.00225	CcSEcCtD
Lovastatin—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000166	0.00224	CcSEcCtD
Lovastatin—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000166	0.00224	CcSEcCtD
Lovastatin—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000166	0.00224	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000165	0.00223	CcSEcCtD
Lovastatin—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000164	0.00222	CcSEcCtD
Lovastatin—Pain—Formoterol—chronic obstructive pulmonary disease	0.000164	0.00222	CcSEcCtD
Lovastatin—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000164	0.00222	CcSEcCtD
Lovastatin—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000164	0.00222	CcSEcCtD
Lovastatin—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000164	0.00222	CcSEcCtD
Lovastatin—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000164	0.00221	CcSEcCtD
Lovastatin—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000163	0.0022	CcSEcCtD
Lovastatin—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000162	0.00219	CcSEcCtD
Lovastatin—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000162	0.00218	CcSEcCtD
Lovastatin—Pain—Montelukast—chronic obstructive pulmonary disease	0.000161	0.00217	CcSEcCtD
Lovastatin—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00016	0.00217	CcSEcCtD
Lovastatin—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.00016	0.00216	CcSEcCtD
Lovastatin—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.00016	0.00216	CcSEcCtD
Lovastatin—Purpura—Prednisone—chronic obstructive pulmonary disease	0.00016	0.00216	CcSEcCtD
Lovastatin—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000159	0.00215	CcSEcCtD
Lovastatin—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000159	0.00215	CcSEcCtD
Lovastatin—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000158	0.00214	CcSEcCtD
Lovastatin—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000158	0.00214	CcSEcCtD
Lovastatin—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000158	0.00214	CcSEcCtD
Lovastatin—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000158	0.00213	CcSEcCtD
Lovastatin—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000157	0.00213	CcSEcCtD
Lovastatin—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000157	0.00212	CcSEcCtD
Lovastatin—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000157	0.00212	CcSEcCtD
Lovastatin—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000156	0.00211	CcSEcCtD
Lovastatin—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000155	0.0021	CcSEcCtD
Lovastatin—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000155	0.0021	CcSEcCtD
Lovastatin—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000154	0.00208	CcSEcCtD
Lovastatin—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000153	0.00206	CcSEcCtD
Lovastatin—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000153	0.00206	CcSEcCtD
Lovastatin—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000152	0.00205	CcSEcCtD
Lovastatin—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000152	0.00205	CcSEcCtD
Lovastatin—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000152	0.00205	CcSEcCtD
Lovastatin—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000152	0.00205	CcSEcCtD
Lovastatin—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000151	0.00204	CcSEcCtD
Lovastatin—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00015	0.00203	CcSEcCtD
Lovastatin—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00015	0.00203	CcSEcCtD
Lovastatin—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00015	0.00202	CcSEcCtD
Lovastatin—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000149	0.00202	CcSEcCtD
Lovastatin—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000149	0.00202	CcSEcCtD
Lovastatin—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000149	0.00201	CcSEcCtD
Lovastatin—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000149	0.00201	CcSEcCtD
Lovastatin—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000149	0.00201	CcSEcCtD
Lovastatin—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000148	0.002	CcSEcCtD
Lovastatin—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000144	0.00195	CcSEcCtD
Lovastatin—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000143	0.00194	CcSEcCtD
Lovastatin—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000143	0.00194	CcSEcCtD
Lovastatin—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000142	0.00191	CcSEcCtD
Lovastatin—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000142	0.00191	CcSEcCtD
Lovastatin—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000141	0.00191	CcSEcCtD
Lovastatin—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000139	0.00187	CcSEcCtD
Lovastatin—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000138	0.00186	CcSEcCtD
Lovastatin—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000138	0.00186	CcSEcCtD
Lovastatin—ABCB1—trachea—chronic obstructive pulmonary disease	0.000137	0.00822	CbGeAlD
Lovastatin—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000136	0.00184	CcSEcCtD
Lovastatin—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000136	0.00184	CcSEcCtD
Lovastatin—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000135	0.00182	CcSEcCtD
Lovastatin—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000134	0.00181	CcSEcCtD
Lovastatin—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000133	0.0018	CcSEcCtD
Lovastatin—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000131	0.00178	CcSEcCtD
Lovastatin—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000131	0.00178	CcSEcCtD
Lovastatin—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.00013	0.00176	CcSEcCtD
Lovastatin—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00013	0.00176	CcSEcCtD
Lovastatin—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000129	0.00174	CcSEcCtD
Lovastatin—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000128	0.00173	CcSEcCtD
Lovastatin—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000127	0.00172	CcSEcCtD
Lovastatin—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000127	0.00172	CcSEcCtD
Lovastatin—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000124	0.00168	CcSEcCtD
Lovastatin—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000124	0.00168	CcSEcCtD
Lovastatin—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000122	0.00165	CcSEcCtD
Lovastatin—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000122	0.00165	CcSEcCtD
Lovastatin—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000122	0.00165	CcSEcCtD
Lovastatin—Rash—Formoterol—chronic obstructive pulmonary disease	0.000121	0.00164	CcSEcCtD
Lovastatin—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000121	0.00164	CcSEcCtD
Lovastatin—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000121	0.00163	CcSEcCtD
Lovastatin—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000121	0.00163	CcSEcCtD
Lovastatin—Headache—Arformoterol—chronic obstructive pulmonary disease	0.00012	0.00163	CcSEcCtD
Lovastatin—Headache—Formoterol—chronic obstructive pulmonary disease	0.00012	0.00163	CcSEcCtD
Lovastatin—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.00012	0.00162	CcSEcCtD
Lovastatin—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00012	0.00162	CcSEcCtD
Lovastatin—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.00012	0.00162	CcSEcCtD
Lovastatin—Rash—Montelukast—chronic obstructive pulmonary disease	0.000119	0.0016	CcSEcCtD
Lovastatin—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000119	0.0016	CcSEcCtD
Lovastatin—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000118	0.0016	CcSEcCtD
Lovastatin—Headache—Montelukast—chronic obstructive pulmonary disease	0.000118	0.00159	CcSEcCtD
Lovastatin—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000116	0.00157	CcSEcCtD
Lovastatin—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000116	0.00157	CcSEcCtD
Lovastatin—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000115	0.00156	CcSEcCtD
Lovastatin—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000115	0.00155	CcSEcCtD
Lovastatin—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000115	0.00155	CcSEcCtD
Lovastatin—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000114	0.00154	CcSEcCtD
Lovastatin—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000114	0.00154	CcSEcCtD
Lovastatin—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000114	0.00154	CcSEcCtD
Lovastatin—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000114	0.00154	CcSEcCtD
Lovastatin—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000114	0.00153	CcSEcCtD
Lovastatin—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000112	0.00151	CcSEcCtD
Lovastatin—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000108	0.00146	CcSEcCtD
Lovastatin—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000107	0.00145	CcSEcCtD
Lovastatin—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000104	0.00141	CcSEcCtD
Lovastatin—Flushing—Prednisone—chronic obstructive pulmonary disease	9.88e-05	0.00133	CcSEcCtD
Lovastatin—ABCB1—lung—chronic obstructive pulmonary disease	9.81e-05	0.00591	CbGeAlD
Lovastatin—Insomnia—Prednisolone—chronic obstructive pulmonary disease	9.41e-05	0.00127	CcSEcCtD
Lovastatin—Alopecia—Prednisone—chronic obstructive pulmonary disease	9.4e-05	0.00127	CcSEcCtD
Lovastatin—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	9.34e-05	0.00126	CcSEcCtD
Lovastatin—Pain—Prednisolone—chronic obstructive pulmonary disease	8.9e-05	0.0012	CcSEcCtD
Lovastatin—Vision blurred—Prednisone—chronic obstructive pulmonary disease	8.73e-05	0.00118	CcSEcCtD
Lovastatin—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	8.6e-05	0.00116	CcSEcCtD
Lovastatin—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	8.57e-05	0.00116	CcSEcCtD
Lovastatin—Angioedema—Prednisone—chronic obstructive pulmonary disease	8.46e-05	0.00114	CcSEcCtD
Lovastatin—Malaise—Prednisone—chronic obstructive pulmonary disease	8.35e-05	0.00113	CcSEcCtD
Lovastatin—Vertigo—Prednisone—chronic obstructive pulmonary disease	8.32e-05	0.00112	CcSEcCtD
Lovastatin—Urticaria—Prednisolone—chronic obstructive pulmonary disease	8.27e-05	0.00112	CcSEcCtD
Lovastatin—Myalgia—Prednisone—chronic obstructive pulmonary disease	7.89e-05	0.00107	CcSEcCtD
Lovastatin—Arthralgia—Prednisone—chronic obstructive pulmonary disease	7.89e-05	0.00107	CcSEcCtD
Lovastatin—Anxiety—Prednisone—chronic obstructive pulmonary disease	7.86e-05	0.00106	CcSEcCtD
Lovastatin—Discomfort—Prednisone—chronic obstructive pulmonary disease	7.79e-05	0.00105	CcSEcCtD
Lovastatin—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	7.67e-05	0.00104	CcSEcCtD
Lovastatin—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	7.56e-05	0.00102	CcSEcCtD
Lovastatin—Infection—Prednisone—chronic obstructive pulmonary disease	7.51e-05	0.00101	CcSEcCtD
Lovastatin—Anorexia—Prednisone—chronic obstructive pulmonary disease	7.21e-05	0.000973	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	6.89e-05	0.00093	CcSEcCtD
Lovastatin—Dizziness—Prednisolone—chronic obstructive pulmonary disease	6.88e-05	0.000929	CcSEcCtD
Lovastatin—Insomnia—Prednisone—chronic obstructive pulmonary disease	6.84e-05	0.000924	CcSEcCtD
Lovastatin—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	6.79e-05	0.000917	CcSEcCtD
Lovastatin—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	6.66e-05	0.000899	CcSEcCtD
Lovastatin—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	6.57e-05	0.000888	CcSEcCtD
Lovastatin—Rash—Prednisolone—chronic obstructive pulmonary disease	6.56e-05	0.000886	CcSEcCtD
Lovastatin—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	6.55e-05	0.000885	CcSEcCtD
Lovastatin—Fatigue—Prednisone—chronic obstructive pulmonary disease	6.52e-05	0.00088	CcSEcCtD
Lovastatin—Headache—Prednisolone—chronic obstructive pulmonary disease	6.52e-05	0.00088	CcSEcCtD
Lovastatin—Constipation—Prednisone—chronic obstructive pulmonary disease	6.47e-05	0.000873	CcSEcCtD
Lovastatin—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	6.23e-05	0.000841	CcSEcCtD
Lovastatin—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	6.18e-05	0.000835	CcSEcCtD
Lovastatin—Nausea—Prednisolone—chronic obstructive pulmonary disease	6.18e-05	0.000835	CcSEcCtD
Lovastatin—Urticaria—Prednisone—chronic obstructive pulmonary disease	6.01e-05	0.000811	CcSEcCtD
Lovastatin—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	5.98e-05	0.000807	CcSEcCtD
Lovastatin—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	5.98e-05	0.000807	CcSEcCtD
Lovastatin—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	5.57e-05	0.000752	CcSEcCtD
Lovastatin—Asthenia—Prednisone—chronic obstructive pulmonary disease	5.42e-05	0.000733	CcSEcCtD
Lovastatin—Pruritus—Prednisone—chronic obstructive pulmonary disease	5.35e-05	0.000722	CcSEcCtD
Lovastatin—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	5.17e-05	0.000699	CcSEcCtD
Lovastatin—Dizziness—Prednisone—chronic obstructive pulmonary disease	5e-05	0.000675	CcSEcCtD
Lovastatin—Vomiting—Prednisone—chronic obstructive pulmonary disease	4.81e-05	0.000649	CcSEcCtD
Lovastatin—Rash—Prednisone—chronic obstructive pulmonary disease	4.77e-05	0.000644	CcSEcCtD
Lovastatin—Dermatitis—Prednisone—chronic obstructive pulmonary disease	4.76e-05	0.000643	CcSEcCtD
Lovastatin—Headache—Prednisone—chronic obstructive pulmonary disease	4.74e-05	0.00064	CcSEcCtD
Lovastatin—Nausea—Prednisone—chronic obstructive pulmonary disease	4.49e-05	0.000607	CcSEcCtD
Lovastatin—SLCO1B1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	2.2e-05	0.00041	CbGpPWpGaD
Lovastatin—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.19e-05	0.000408	CbGpPWpGaD
Lovastatin—HDAC2—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	2.18e-05	0.000406	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.18e-05	0.000406	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2.17e-05	0.000404	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—GC—chronic obstructive pulmonary disease	2.15e-05	0.000399	CbGpPWpGaD
Lovastatin—CYP2D6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.13e-05	0.000396	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—EGFR—chronic obstructive pulmonary disease	2.12e-05	0.000394	CbGpPWpGaD
Lovastatin—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.11e-05	0.000392	CbGpPWpGaD
Lovastatin—CYP2D6—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.1e-05	0.00039	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—APIP—chronic obstructive pulmonary disease	2.08e-05	0.000388	CbGpPWpGaD
Lovastatin—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.08e-05	0.000387	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.06e-05	0.000383	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	2.02e-05	0.000377	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—GSTT1—chronic obstructive pulmonary disease	2.02e-05	0.000375	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	2.01e-05	0.000373	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—ALB—chronic obstructive pulmonary disease	2e-05	0.000373	CbGpPWpGaD
Lovastatin—HDAC2—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	2e-05	0.000372	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.99e-05	0.000371	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—GCLC—chronic obstructive pulmonary disease	1.99e-05	0.000371	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.98e-05	0.000369	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	1.97e-05	0.000367	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—EGFR—chronic obstructive pulmonary disease	1.96e-05	0.000365	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—NOS3—chronic obstructive pulmonary disease	1.92e-05	0.000356	CbGpPWpGaD
Lovastatin—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	1.91e-05	0.000356	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	1.9e-05	0.000354	CbGpPWpGaD
Lovastatin—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	1.89e-05	0.000351	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.86e-05	0.000347	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	1.86e-05	0.000346	CbGpPWpGaD
Lovastatin—HDAC2—Disease—KL—chronic obstructive pulmonary disease	1.85e-05	0.000343	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—CTGF—chronic obstructive pulmonary disease	1.82e-05	0.000338	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	1.82e-05	0.000338	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	1.81e-05	0.000336	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.73e-05	0.000322	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.71e-05	0.000319	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.71e-05	0.000319	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—APIP—chronic obstructive pulmonary disease	1.71e-05	0.000318	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	1.7e-05	0.000316	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—GCLC—chronic obstructive pulmonary disease	1.69e-05	0.000315	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.69e-05	0.000315	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	1.69e-05	0.000314	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.68e-05	0.000312	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—IL6—chronic obstructive pulmonary disease	1.63e-05	0.000303	CbGpPWpGaD
Lovastatin—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	1.6e-05	0.000297	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.59e-05	0.000297	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.58e-05	0.000293	CbGpPWpGaD
Lovastatin—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	1.57e-05	0.000293	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—GC—chronic obstructive pulmonary disease	1.55e-05	0.000289	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—CTGF—chronic obstructive pulmonary disease	1.55e-05	0.000288	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—IL6—chronic obstructive pulmonary disease	1.51e-05	0.00028	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.49e-05	0.000278	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.49e-05	0.000278	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.49e-05	0.000277	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—GCLC—chronic obstructive pulmonary disease	1.48e-05	0.000275	CbGpPWpGaD
Lovastatin—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.47e-05	0.000273	CbGpPWpGaD
Lovastatin—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.45e-05	0.000269	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.44e-05	0.000268	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.43e-05	0.000265	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.4e-05	0.00026	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.39e-05	0.000259	CbGpPWpGaD
Lovastatin—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.39e-05	0.000259	CbGpPWpGaD
Lovastatin—HDAC2—Disease—ERBB3—chronic obstructive pulmonary disease	1.38e-05	0.000257	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.38e-05	0.000257	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—VEGFA—chronic obstructive pulmonary disease	1.38e-05	0.000257	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.38e-05	0.000257	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.38e-05	0.000256	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.38e-05	0.000256	CbGpPWpGaD
Lovastatin—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.37e-05	0.000255	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.37e-05	0.000255	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—CTGF—chronic obstructive pulmonary disease	1.35e-05	0.000251	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GC—chronic obstructive pulmonary disease	1.34e-05	0.00025	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.33e-05	0.000247	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.31e-05	0.000243	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.29e-05	0.00024	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.28e-05	0.000239	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.28e-05	0.000238	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—TGFB1—chronic obstructive pulmonary disease	1.27e-05	0.000236	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—GCLC—chronic obstructive pulmonary disease	1.26e-05	0.000235	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.26e-05	0.000234	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.25e-05	0.000232	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.24e-05	0.000231	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.23e-05	0.000229	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.22e-05	0.000227	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.22e-05	0.000227	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.21e-05	0.000225	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.2e-05	0.000224	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	1.2e-05	0.000223	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.19e-05	0.000222	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.19e-05	0.000222	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.19e-05	0.000221	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	1.18e-05	0.000219	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.17e-05	0.000218	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.17e-05	0.000218	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	1.17e-05	0.000218	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—GCLC—chronic obstructive pulmonary disease	1.16e-05	0.000216	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.16e-05	0.000215	CbGpPWpGaD
Lovastatin—HDAC2—Disease—NOS2—chronic obstructive pulmonary disease	1.15e-05	0.000215	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—CTGF—chronic obstructive pulmonary disease	1.15e-05	0.000214	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.13e-05	0.000211	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.12e-05	0.000209	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.12e-05	0.000208	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.12e-05	0.000208	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.11e-05	0.000207	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.11e-05	0.000207	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GC—chronic obstructive pulmonary disease	1.1e-05	0.000205	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	1.09e-05	0.000203	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—GSTM1—chronic obstructive pulmonary disease	1.09e-05	0.000203	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.09e-05	0.000202	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.07e-05	0.000198	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	1.06e-05	0.000197	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—CTGF—chronic obstructive pulmonary disease	1.06e-05	0.000197	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	1.05e-05	0.000195	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—TP53—chronic obstructive pulmonary disease	1.04e-05	0.000194	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	1.04e-05	0.000193	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—GSTP1—chronic obstructive pulmonary disease	1.03e-05	0.000193	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.03e-05	0.000191	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—HMOX1—chronic obstructive pulmonary disease	1.02e-05	0.00019	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.02e-05	0.000189	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—ALB—chronic obstructive pulmonary disease	1.02e-05	0.000189	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	9.95e-06	0.000185	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.74e-06	0.000181	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	9.72e-06	0.000181	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—NOS3—chronic obstructive pulmonary disease	9.71e-06	0.000181	CbGpPWpGaD
Lovastatin—HDAC2—Disease—SERPINE1—chronic obstructive pulmonary disease	9.71e-06	0.000181	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	9.69e-06	0.00018	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	9.66e-06	0.00018	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	9.53e-06	0.000177	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—GSTM1—chronic obstructive pulmonary disease	9.51e-06	0.000177	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	9.33e-06	0.000174	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	9.32e-06	0.000173	CbGpPWpGaD
Lovastatin—HDAC2—Disease—NOS3—chronic obstructive pulmonary disease	9.27e-06	0.000173	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	9.02e-06	0.000168	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	8.92e-06	0.000166	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	8.88e-06	0.000165	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.88e-06	0.000165	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.85e-06	0.000165	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	8.75e-06	0.000163	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.73e-06	0.000162	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	8.67e-06	0.000161	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.47e-06	0.000158	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	8.41e-06	0.000157	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—GCLC—chronic obstructive pulmonary disease	8.37e-06	0.000156	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	8.33e-06	0.000155	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—ALB—chronic obstructive pulmonary disease	8.28e-06	0.000154	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—GSTM1—chronic obstructive pulmonary disease	8.13e-06	0.000151	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.12e-06	0.000151	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	8.1e-06	0.000151	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.01e-06	0.000149	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—NOS3—chronic obstructive pulmonary disease	7.92e-06	0.000147	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.71e-06	0.000143	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—CTGF—chronic obstructive pulmonary disease	7.64e-06	0.000142	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.46e-06	0.000139	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.41e-06	0.000138	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	7.35e-06	0.000137	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.34e-06	0.000137	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GCLC—chronic obstructive pulmonary disease	7.25e-06	0.000135	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	7.21e-06	0.000134	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.08e-06	0.000132	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.04e-06	0.000131	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—ALB—chronic obstructive pulmonary disease	7.04e-06	0.000131	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	6.8e-06	0.000127	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	6.76e-06	0.000126	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—NOS3—chronic obstructive pulmonary disease	6.73e-06	0.000125	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.7e-06	0.000125	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—CTGF—chronic obstructive pulmonary disease	6.62e-06	0.000123	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.55e-06	0.000122	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	6.49e-06	0.000121	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	6.47e-06	0.00012	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.39e-06	0.000119	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	6.32e-06	0.000118	CbGpPWpGaD
Lovastatin—HDAC2—Disease—TGFB1—chronic obstructive pulmonary disease	6.13e-06	0.000114	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—ALB—chronic obstructive pulmonary disease	6.13e-06	0.000114	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—CYP1A2—chronic obstructive pulmonary disease	6.1e-06	0.000113	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	6.04e-06	0.000112	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.02e-06	0.000112	CbGpPWpGaD
Lovastatin—HDAC2—Disease—EGFR—chronic obstructive pulmonary disease	6.01e-06	0.000112	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.97e-06	0.000111	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GCLC—chronic obstructive pulmonary disease	5.95e-06	0.000111	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	5.91e-06	0.00011	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	5.9e-06	0.00011	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.87e-06	0.000109	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—NOS3—chronic obstructive pulmonary disease	5.86e-06	0.000109	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.79e-06	0.000108	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	5.77e-06	0.000107	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	5.76e-06	0.000107	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—ALB—chronic obstructive pulmonary disease	5.72e-06	0.000106	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.6e-06	0.000104	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	5.5e-06	0.000102	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—NOS3—chronic obstructive pulmonary disease	5.47e-06	0.000102	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.44e-06	0.000101	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CTGF—chronic obstructive pulmonary disease	5.43e-06	0.000101	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.4e-06	0.0001	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	5.39e-06	0.0001	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.31e-06	9.89e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—ALB—chronic obstructive pulmonary disease	5.24e-06	9.75e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	5.21e-06	9.69e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.12e-06	9.52e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.09e-06	9.46e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.02e-06	9.33e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—NOS3—chronic obstructive pulmonary disease	5.01e-06	9.33e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.01e-06	9.32e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.96e-06	9.23e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—ALB—chronic obstructive pulmonary disease	4.81e-06	8.95e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	4.68e-06	8.7e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.67e-06	8.7e-05	CbGpPWpGaD
Lovastatin—HDAC2—Disease—IL6—chronic obstructive pulmonary disease	4.62e-06	8.6e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—NOS3—chronic obstructive pulmonary disease	4.6e-06	8.56e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.54e-06	8.45e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.48e-06	8.33e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.43e-06	8.24e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.43e-06	8.24e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.37e-06	8.13e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.29e-06	7.99e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.21e-06	7.83e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.18e-06	7.77e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.17e-06	7.76e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.14e-06	7.7e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.12e-06	7.66e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.08e-06	7.6e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.07e-06	7.58e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.95e-06	7.36e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.94e-06	7.33e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	3.89e-06	7.24e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.86e-06	7.18e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.84e-06	7.14e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.8e-06	7.08e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.64e-06	6.77e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.61e-06	6.71e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	3.55e-06	6.61e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	3.53e-06	6.58e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—ALB—chronic obstructive pulmonary disease	3.48e-06	6.47e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—NOS3—chronic obstructive pulmonary disease	3.33e-06	6.19e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.27e-06	6.09e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.24e-06	6.02e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—ALB—chronic obstructive pulmonary disease	3.01e-06	5.6e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—NOS3—chronic obstructive pulmonary disease	2.88e-06	5.36e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.73e-06	5.08e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.69e-06	5.01e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	2.69e-06	5e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	2.62e-06	4.88e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	2.57e-06	4.78e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	2.51e-06	4.67e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.51e-06	4.67e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ALB—chronic obstructive pulmonary disease	2.47e-06	4.6e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	2.45e-06	4.56e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.38e-06	4.43e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—NOS3—chronic obstructive pulmonary disease	2.36e-06	4.4e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	2.34e-06	4.36e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.62e-06	3.01e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.55e-06	2.88e-05	CbGpPWpGaD
